APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 57 filers reported holding APTOSE BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 1.25 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,488 | -96.2% | 11,700 | -96.6% | 0.00% | – |
| Q4 2022 | $199,106 | -99.9% | 343,286 | +0.8% | 0.00% | – |
| Q3 2022 | $202,649,000 | -20.2% | 340,586 | -0.5% | 0.00% | – |
| Q2 2022 | $253,936,000 | -72.8% | 342,186 | -50.1% | 0.00% | -100.0% |
| Q1 2022 | $933,039,000 | +0.7% | 686,058 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $926,178,000 | +24.7% | 686,058 | +101.4% | 0.00% | 0.0% |
| Q3 2021 | $742,477,000 | -34.3% | 340,586 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,130,746,000 | -44.4% | 340,586 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $2,035,001,000 | +36.4% | 340,586 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,491,767,000 | -27.0% | 340,586 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,043,516,000 | -4.9% | 340,586 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $2,149,098,000 | +116.3% | 340,586 | +103.6% | 0.00% | +100.0% |
| Q1 2020 | $993,679,000 | – | 167,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 690,000 | $4,123,000 | 3.63% |
| DRW Securities, LLC | 7,976,176 | $47,658,000 | 1.89% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $8,420,000 | 1.61% |
| Nantahala Capital Management | 7,738,892 | $46,240,000 | 1.35% |
| PRECEPT MANAGEMENT LLC | 330,766 | $1,976,000 | 1.35% |
| First Light Asset Management, LLC | 3,102,788 | $18,539,000 | 1.23% |
| Voss Capital, LLC | 440,000 | $2,629,000 | 1.10% |
| VR Adviser, LLC | 1,605,400 | $9,592,000 | 1.04% |
| Endurant Capital Management LP | 517,472 | $3,092,000 | 0.81% |
| Opaleye Management Inc. | 871,800 | $5,209,000 | 0.76% |